CPDA

CAS No. 1415834-63-7

CPDA( —— )

Catalog No. M26128 CAS No. 1415834-63-7

CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 79 Get Quote
10MG 125 Get Quote
25MG 251 Get Quote
50MG 475 Get Quote
100MG 692 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CPDA
  • Note
    Research use only, not for human use.
  • Brief Description
    CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).
  • Description
    CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).(In Vitro):CPDA enhances insulin signaling.(In Vivo):CPDA greatly improves abnormal glucose metabolism in diabetic animals. In db/db mice, CPDA improves abnormal glucose metabolism.
  • In Vitro
    CPDA enhances insulin signaling.
  • In Vivo
    CPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA improves the abnormal glucose metabolism in db/db mice.
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    Smoothened
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1415834-63-7
  • Formula Weight
    388.8
  • Molecular Formula
    C20H15ClF2N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 50 mg/mL (128.60 mM)
  • SMILES
    Fc1cccc(F)c1CC(=O)Nc1cc(OCc2ccc(Cl)cc2)ccn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Solinas et al (2012) Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity. J.Med.Chem. 55 1559
molnova catalog
related products
  • BCI hydrochloride

    BCI hydrochloride ((E)-BCI hydrochloride) is a selective dual-specificity phosphatase 6 (DUSP6) inhibitor that inhibits RANKL-mediated osteoclastogenesis and attenuates oophorectomy-induced bone loss.

  • h-NTPDase-IN-2

    h-NTPDase-IN-2 is a broad-spectrum NTPDase inhibitor that inhibits multiple h-NTPDas isoforms.

  • Microcystin-LA

    Microcystin LA, a natural toxin, exerts its cytotoxic exects by inhibiting the serine-threonine protein phosphatases PP1 and PP2A with IC50s of 0.3 and 0.3 nM, respectively.